News – Page 60 – Endpoints News

Numab extends its Series C; AnaCardio raises $19M for its heart failure drug

4 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

4 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

4 months ago

Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners

4 months ago

Coave raises €32M Series A despite being two years away from the clinic

4 months ago

H1 buys General Catalyst-backed Ribbon Health

4 months ago

Aiolos team reunites with $411M for new biotech with obesity drugs from China

4 months ago

MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment

5 months ago

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

5 months ago

Revance weighs competing buyout offer amid push from original bidder

5 months ago

Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request

5 months ago

Ahead of adcomm, FDA discusses Seikagaku's mixed trial results for its lumbar disc herniation injection

5 months ago

Astellas stops developing autologous cell therapy using tech from Xyphos buyout

5 months ago

Transcarent buys health navigation incumbent Accolade for $621M

5 months ago

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

5 months ago

Resilience cuts 120 employees at a former bluebird gene therapy site

5 months ago

Sana’s stock soars on new cell therapy data; UniQure’s $75M offering

5 months ago

Solid Bio's former CEO launches new rare disease startup with €65M Series A

5 months ago

Roche's Chugai partners with Swiss ADC biotech Araris

5 months ago

ARCH, F-Prime and Mubadala pump $200M into former Denali programs

5 months ago

‘Too elegant to ignore’: Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies

5 months ago

Exclusive: GV-backed startup Prudentia launches with $7M to help pharma make better deals, faster

5 months ago

Vir’s early T cell engager data offer first look at cancer pivot, stock jumps

5 months ago

Updated: Galapagos to split into two companies, slash headcount as it eyes turnaround

5 months ago

First page Previous page 57 58 596061 62 63 Next page Last page